Eldelumab Completed Phase 1 Trials for Ulcerative Colitis (UC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00295282A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis